Needle-Free Diabetes Care Market Research Report- Forecast To 2027

Needle-Free Diabetes Care Market Research Report, By Devices Types (Treatment Devices And Diagnostic Devices), Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others), Application (Insulin Delivery And Other), End Users (Diagnostic Centers, Hospitals & Clinics And Other)-Forecast Till 2027

ID: MRFR/MED/0407-HCR | February 2021 | Region: Global | 110 pages

Needle-Free Diabetes Care Market Overview


The needle-free diabetes care market is anticipated to grow at a high speed in the years to come. The needle-free diabetes healthcare market value is anticipated to grow at 7.5% CAGR by 2023. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.


Diabetes may be termed as a group of metabolic disorders, caused due to insulin deficiency. Needle-free medication is growing popular because it is a modern option to administer pain-free insulin medication to the patient. The diabetic population is multiplying around the world, which is expected to drive the needle-free diabetes care market growth.


Moreover, a large share of the population is also suffering from obesity. This has led to a rise in healthcare expenditure. The government is also rendering strong support for medication facilities, which will contribute to the growth of the market. Studies show that smoking adds to the probability of having diabetes in people. Moreover, more than 60% of the global population comprises smokers. This fact is also known to increase the risk of diabetes and may fuel the growth of the needle-free healthcare market.


Covid-19 Analysis


With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The needle-less diabetes healthcare market saw a slight downfall post the pandemic, due to the lockdown and physical distancing.


However, the key companies have adopted measures to sell needle-free diabetes medication online. Moreover, people are growing aware of the need for needle-less diabetes healthcare provisions. Hence, these factors are expected to boost the growth of the needle-free diabetes care market value in the years to come.


Market Dynamics


Drivers


A few factors may drive the growth of the needle-free diabetes care market share. There have been increasing cases of diabetes and obesity in the population around the globe. These cases have contributed to the hike in healthcare expenditure for the people. Moreover, the government has been rendering strong support to the development of needle-free medication for diabetes. Hence, these factors are expected to accelerate global market growth.


Opportunities


The major companies that account for the largest needle-free diabetes care market share are adopting various trends such as new product launches in the field. The advancements in technology and research are adding to its growth. Moreover, most companies are adopting R&D market trends. Hence, these factors serve as opportunities for global market growth.


Restraints


There are a few factors that may inhibit the growth of the needle-free diabetes care market. One of the most important of them is the lack of awareness among people regarding the use of needle-free healthcare. Moreover, these needle-less diabetes care products are a bit expensive. Hence, these factors may hinder market growth.


Challenges


Some factors that may challenge the key diabetes healthcare providers include the cost of needle-free products. They are quite expensive and are not affordable to the majority of the diabetic population around the globe. These needle-free care products are also not available that easily. Hence, these factors challenge the key companies of the global market.


Cumulative Growth Analysis


The needle-free diabetes care market is anticipated to grow at a high speed in the years to come. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.


Value Chain Analysis


People are growing aware of needle-free diabetes healthcare products. These products are growing popular because of the numerous benefits they offer, without having to hurt your skin or body. Many key companies of the market have also adopted trends such as innovations and product launches. The government is also supporting market research and development. Hence, these factors may fuel the growth of the industry in the global needle-free diabetes care market forecast.


Segment Overview


The global needle-free diabetes care market is classified into many segments such as device types, treatment, application, and end-user. Listed below are the needle-less diabetes healthcare market segments:


By Device Types



  • Diagnostic devices


    • Instant glucose monitoring

    • Continuous glucose monitoring


  • Treatment devices


    • Insulin pen

    • Insulin patch

    • Insulin pump

    • Insulin inhaler

    • Insulin jet injector



By Treatment



  • Insulin patch

  • Inhaled insulin

  • Oral insulin

  • Others


By Application



  • Insulin delivery

  • Others


By End-user



  • Hospitals & clinics

  • Diagnostic centres

  • Others


Regional Analysis


The regional division of the needle-free diabetes care market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. Among them, North America is expected to rule over the global market over the forecast period (2022 – 2027). This is because most of the obese and diabetic population in the globe belongs to the North American region.


Moreover, there are huge changes in the lifestyle of people to maintain their health. This region will be followed by Europe, with the second-largest share in the global needle-free diabetes care industry. However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of the diabetic population.


Competitive Landscape


The needle-free diabetes care industry is dominated by a few companies that play a vital role in the growth of the market. These healthcare companies are called the key companies of the market. They contribute to the largest share of the market profit.


The companies account for the market profits by adopting various needle-free diabetes care market trends such as joint ventures, product launches, company expansions, and procurements. They are innovative insulin medication options for diabetic patients.


Key Players


Below are the key companies that offer needle-free diabetes care in the global market, with the location of their headquarters:



  • Medical International Technology Inc. (US)

  • European Pharma Group (Netherland)

  • Zogenix Inc. (US)

  • Antares Pharma Inc. (US)

  • Valeritas Inc. (US)

  • 3M Company (US)

  • Endo International plc. (US)

  • INJEX Pharma AG (Germany)

  • Bioject Medical Technologies Inc. (US)

  • Crossject SA (France)

  • PharmaJet (US)

  • PenJet Corporation (US)


Recent Developments 



  • Echo Therapeutics has developed a needle-free diabetic tester that uses a patch instead of a needle poke. The transdermal biosensor examines the blood analytes through the skin with blood drawn from the body.

  • DiaMonTech launched its diabetes monitor D-Base that measures blood glucose levels by passing an infrared ray through the skin. The levels are evaluated by monitoring the temperature changes on the skin.

  • Portal Instruments launched its jet-injection device that injects insulin into the skin through a ‘hair-thin’ stream.


Report Overview


This report delivers all the information about the growth of the global needle-free diabetes care market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected needle-free diabetes care market outlook by the year 2027.


Geographically



  • Europe

  • Asia-Pacific

  • North America

  • Middle East & Africa

  • Rest of the world



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Devices Types, Treatment, Application, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Antares Pharma, Inc. (US), Bioject Medical Technologies Inc. (US), Endo International plc (US), European Pharma Group (Netherland), PharmaJet (US), Medical International Technology, Inc. (US), Valeritas, Inc. (US), PenJet Corporation (US), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Crossject SA (France), Zogenix, Inc. (US), 3M Company (US).
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing diabetic population
  • Increasing obese population
  • Increasing healthcare expenditure
  • Strong encouragement from the government


  • Speak to Analyst Ask for Customization

    TABLE OF CONTENTS

    1 INTRODUCTION

    1.1 DEFINITION

    1.2 SCOPE OF STUDY

    1.2.1 RESEARCH OBJECTIVE

    1.2.2 ASSUMPTIONS & LIMITATIONS

    1.2.2.1 ASSUMPTIONS

    1.2.2.2 LIMITATIONS

    1.3 MARKET STRUCTURE:

    2 RESEARCH METHODOLOGY

    2.1 RESEARCH PROCESS:

    2.2 PRIMARY RESEARCH

    2.3 SECONDARY RESEARCH:

    3 MARKET DYNAMICS

    3.1 DRIVERS

    3.2 RESTRAINTS

    3.3 OPPORTUNITIES

    3.4 MACROECONOMIC INDICATORS

    4 MARKET FACTOR ANALYSIS

    4.1 PORTERS FIVE FORCES MODEL

    4.2 BARGAINING POWER OF SUPPLIERS

    4.3 BARGAINING POWER OF BUYERS

    4.4 THREAT OF NEW ENTRANTS

    4.5 THREAT OF SUBSTITUTES

    4.6 INTENSITY OF RIVALRY

    5. GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY DEVICES TYPE

    5.1 TREATMENT DEVICES

    5.1.1 INSULIN JET INJECTOR

    5.1.2 INSULIN PEN

    5.1.3 INSULIN INHALER

    5.1.4 INSULIN PATCH & PUMP.

    5.2 DIAGNOSTIC DEVICES

    5.2.1 CONTINUOUS GLUCOSE MONITORING

    5.2.2 INSTANT GLUCOSE MONITORING

    6 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY TREATMENT

    6.1 ORAL INSULIN

    6.2 INHALED INSULIN

    6.3 INSULIN PATCH

    6.4 OTHERS

    7 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY APPLICATION

    7.1 INSULIN DELIVERY

    7.2 OTHER

    8 GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY END USER

    8.1 DIAGNOSTIC CENTERS

    8.2 HOSPITALS & CLINICS

    8.3 OTHERS

    9. GLOBAL NEEDLE-FREE DIABETES CARE MARKET, BY REGION

    9.1 INTRODUCTION

    9.2 AMERICA

    9.2.1 NORTH AMERICA

    9.2.1.1 US

    9.2.1.2 CANADA

    9.2.2 SOUTH AMERICA

    9.3 EUROPE

    9.3.1 WESTERN EUROPE

    9.3.1.1 GERMANY

    9.3.1.2 FRANCE

    9.3.1.3 ITALY

    9.3.1.3 SPAIN

    9.3.1.5 UK

    9.3.1.6 REST OF WESTERN EUROPE

    9.3.2 EASTERN EUROPE

    9.4 ASIA PACIFIC

    9.4.1 JAPAN

    9.4.2 CHINA

    9.4.3 INDIA

    9.4.4 AUSTRALIA

    9.4.5 REPUBLIC OF KOREA

    9.4.6 REST OF ASIA-PACIFIC

    9.5 MIDDLE EAST & AFRICA

    9.5.1 UNITED ARAB EMIRATES

    9.5.2 SAUDI ARABIA

    9.5.3 OMAN

    9.5.4 KUWAIT

    9.5.5 QATAR

    9.5.6 REST OF MIDDLE EAST & AFRICA

    10 COMPETITIVE LANDSCAPE

    10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

    10.1.1 STRATEGIC PARTNERSHIP

    10.1.2 MERGER & ACQUISITION

    11 COMPANY PROFILE

    11.1 ANTARES PHARMA, INC.

    11.1.1 OVERVIEW

    11.1.2 PRODUCT OVERVIEW

    11.1.3 FINANCIALS

    11.1.4 KEY DEVELOPMENTS

    11.2 BIOJECT MEDICAL TECHNOLOGIES INC

    11.2.1 OVERVIEW

    11.2.2 PRODUCT OVERVIEW

    11.2.3 FINANCIALS

    11.2.4 KEY DEVELOPMENTS

    11.3 INJEX PHARMA AG

    11.3.1 OVERVIEW

    11.3.2 PRODUCT OVERVIEW

    11.3.3 FINANCIALS

    11.3.4 KEY DEVELOPMENT

    11.4 MEDICAL INTERNATIONAL TECHNOLOGY, INC

    11.4.1 OVERVIEW

    11.4.2 PRODUCT OVERVIEW

    11.4.3 FINANCIALS

    11.4.4 KEY DEVELOPMENTS

    11.5 NATIONAL MEDICAL PRODUCTS INC

    11.5.1 OVERVIEW

    11.5.2 PRODUCT OVERVIEW

    11.5.3 FINANCIALS

    11.5.4 KEY DEVELOPMENTS

    11.6 PENJET CORPORATION

    11.6.1 OVERVIEW

    11.6.2 PRODUCT OVERVIEW

    11.6.3 FINANCIALS

    11.6.4 KEY DEVELOPMENTS

    11.7 ZOGENIX, INC.

    11.7.1 OVERVIEW

    11.7.2 PRODUCT OVERVIEW

    11.7.3 FINANCIALS

    11.7.4 KEY DEVELOPMENTS

    11.8 OTHERS

    12 CONCLUSION

    12.1 KEY FINDINGS

    12.1.1 FROM CEO’S VIEWPOINT

    12.1.2 UNMET NEEDS OF THE MARKET

    12.2 KEY COMPANIES TO WATCH

    12.3 PREDICTION OF DIABETIC CARE INDUSTRY

    13 APPENDIX

    LIST OF TABLES

    Table 1 Needle Free Diabetes Care Industry Synopsis, 2020-2027

    Table 2 Global Needle Free Diabetes Care Market Estimates & Forecast, 2020-2027, (USD Million)

    Table 3 Global Needle Free Diabetes Care Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)

    Table 5 Global Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 6 Global Needle Free Diabetes Care Market, by Instruments, 2020-2027, (USD Million)

    Table 7 Global Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 8 North America Needle Free Diabetes Care Market, by Device Type, 2020-2027,

    (USD Million)

    Table 9 North America Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 10 North America Needle Free Diabetes Care Market, by Application, 2020-2027,

    (USD Million)

    Table 11 North America Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 12 U.S. Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)

    Table 13 U.S. Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 14 U.S. Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)

    Table 15 U.S. Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 16 Canada Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)

    Table 17 Canada Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 18 Canada Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)

    Table 19 Canada Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 20 South America Needle Free Diabetes Care Market, by Device Type, 2020-2027,

    (USD Million)

    Table 21 South America Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 22 South America Needle Free Diabetes Care Market, by Application, 2020-2027,

    (USD Million)

    Table 23 South America Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 24 Europe Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)

    Table 25 Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 26 Europe Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)

    Table 27 Europe Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 28 Western Europe Needle Free Diabetes Care Market by Device Type, 2020-2027,

    (USD Million)

    Table 29 Western Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027,

    (USD Million)

    Table 30 Western Europe Needle Free Diabetes Care Market, by Application, 2020-2027,

    (USD Million)

    Table 31 Western Europe Needle Free Diabetes Care Market, by End-User, 2020-2027,

    (USD Million)

    Table 32 Eastern Europe Needle Free Diabetes Care Market, by Device Type, 2020-2027,

    (USD Million)

    Table 33 Eastern Europe Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 34 Eastern Europe Needle Free Diabetes Care Market, by Application, 2020-2027,

    (USD Million)

    Table 35 Eastern Europe Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 36 Asia Pacific Needle Free Diabetes Care Market, by Device Type, 2020-2027, (USD Million)

    Table 37 Asia Pacific Needle Free Diabetes Care Market, by Treatment, 2020-2027, (USD Million)

    Table 38 Asia Pacific Needle Free Diabetes Care Market, by Application, 2020-2027, (USD Million)

    Table 39 Asia Pacific Needle Free Diabetes Care Market, by End-User, 2020-2027, (USD Million)

    Table 40 Middle East & Africa Needle Free Diabetes Care Market, by Device Type, 2020-2027,

    (USD Million)

    Table 41 Middle East & Africa Needle Free Diabetes Care Market, by Treatment, 2020-2027,

    (USD Million)

    Table 42 Middle East & Africa Needle Free Diabetes Care Market, by Application, 2020-2027,

    (USD Million)

    Table 43 Middle East & Africa Needle Free Diabetes Care Market, by End-User, 2020-2027,

    (USD Million) 


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Needle Free Diabetes Care Market

    Figure 3 Segmentation Market Dynamics for Needle Free Diabetes Care Market

    Figure 4 Global Needle Free Diabetes Care Market Share, by Device Type, 2020 (%)

    Figure 5 Global Needle Free Diabetes Care Market Share, by Treatment, 2020 (%)

    Figure 6 Global Needle Free Diabetes Care Market Share, by Application, 2020 (%)

    Figure 7 Global Needle Free Diabetes Care Market Share, by End-User, 2020 (%)

    Figure 8 Global Needle Free Diabetes Care Market Share, by Region, 2020 (%)

    Figure 9 North America Needle Free Diabetes Care Market Share, by Country, 2020 (%)

    Figure 10 Europe Needle Free Diabetes Care Market Share, by Country, 2020 (%)

    Figure 11 Asia Pacific Needle Free Diabetes Care Market Share, by Country, 2020 (%)

    Figure 12 Middle East & Africa Needle Free Diabetes Care Market Share, by Country, 2020 (%)

    Figure 13 Global Needle Free Diabetes Care Market: Company Share Analysis, 2020 (%)